IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,606,685 | +13629.3% | 721,075 | +2693.9% | 0.02% | – |
| Q1 2023 | $99,107 | +77327.3% | 25,809 | 0.0% | 0.00% | – |
| Q4 2022 | $128 | -99.8% | 25,809 | +60.3% | 0.00% | – |
| Q3 2022 | $77,000 | +5.5% | 16,100 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -5.2% | 16,100 | 0.0% | 0.00% | – |
| Q1 2022 | $77,000 | -35.3% | 16,100 | 0.0% | 0.00% | – |
| Q4 2021 | $119,000 | +30.8% | 16,100 | 0.0% | 0.00% | – |
| Q3 2021 | $91,000 | – | 16,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |